These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 6420440

  • 1. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 2. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    Huseman CA.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
    [Abstract] [Full Text] [Related]

  • 3. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA, Hassing JM, Sibilia MG.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
    [Abstract] [Full Text] [Related]

  • 4. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC, Bordenick S, Heavner G, Rose S, Hintz R, Rosenfeld R, Chrousos GP.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [Abstract] [Full Text] [Related]

  • 5. Serum luteinizing hormone and follicle-stimulating hormone and the response to luteinizing hormone-releasing factor in children and adolescents with isolated growth hormone deficiency.
    Cohen HN, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1983 Oct; 57(4):855-8. PubMed ID: 6411756
    [Abstract] [Full Text] [Related]

  • 6. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):152-9. PubMed ID: 3889035
    [Abstract] [Full Text] [Related]

  • 7. LH and FSH responsiveness to intravenous gonadotropin-releasing hormone (GnRH) in children with hypothalamic or pituitary disorders: lack of effect of replacement therapy with human growth hormone.
    Kelch RP, Markovs M, Huss J.
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1104-13. PubMed ID: 777020
    [Abstract] [Full Text] [Related]

  • 8. Somatomedin-C and growth in children with precocious puberty: a study of the effect of the level of growth hormone secretion.
    Rappaport R, Prevot C, Brauner R.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1112-7. PubMed ID: 3680478
    [Abstract] [Full Text] [Related]

  • 9. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Coude FX, Arnone M, Morre M, Uboldi F, Barbeau C.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of the somatomedin C/insulin-like growth factor I: response to exogenous growth hormone (GH) in GH-deficient children.
    Blethen SL, Daughaday WH, Weldon VV.
    J Clin Endocrinol Metab; 1982 May; 54(5):986-90. PubMed ID: 7037825
    [Abstract] [Full Text] [Related]

  • 11. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 12. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [Abstract] [Full Text] [Related]

  • 13. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids.
    Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1990 Oct; 71(4):975-83. PubMed ID: 2401720
    [Abstract] [Full Text] [Related]

  • 14. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
    Mauras N, Rogol AD, Veldhuis JD.
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
    [Abstract] [Full Text] [Related]

  • 15. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [Abstract] [Full Text] [Related]

  • 17. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP, Barkan AL, Kletter GB, Beitins IZ, Foster CM.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [Abstract] [Full Text] [Related]

  • 18. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G, Weekers F, Baxter RC, Wouters P, Iranmanesh A, Bouillon R, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [Abstract] [Full Text] [Related]

  • 19. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 20. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.